Pharming B.V.
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Industrial and Commercial Machinery and Equipment, Not Elsewhere Classified), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about Pharming B.V.
Live alerts from global media, monitored by Business Radar
2024-10-01 (iex.nl)
Closing call: day's profit evaporates due to threat of Iranian missile attack, VIX shoots up
AEX sees previous profits melt away due to increasing tensions in the Middle East. VIX, oil, gold and defense stocks are skyrocketing. Chip stocks still down.
Read more
2024-10-01 (iex.nl)
Closing call: day's profit evaporates due to threat of Iranian missile attack, VIX shoots up
AEX sees previous profits melt away due to increasing tensions in the Middle East. VIX, oil, gold and defense stocks are skyrocketing. Chip stocks still down.
Read more
2024-09-04 (businessupturn.com)
Pharming Group to participate in September investor conferences
Leiden, the Netherlands, September4, 2024: Pharming Group N.V.(“ Pharming”)( Euronext Amsterdam: PHARM/Nasdaq: PHAR) announces that Pharming’ s management will participate in the following investor conferences in the U.S. in the month of September: 2024 Wells Fargo Healthcare Conference, Boston,
Read more
2024-09-04 (businessupturn.com)
Pharming Group to participate in September investor conferences
Leiden, the Netherlands, September4, 2024: Pharming Group N.V.(“ Pharming”)( Euronext Amsterdam: PHARM/Nasdaq: PHAR) announces that Pharming’ s management will participate in the following investor conferences in the U.S. in the month of September: 2024 Wells Fargo Healthcare Conference, Boston,
Read more
2024-05-21 (iex.nl)
Pharming annual meeting agrees to all agenda items
Pharming's annual meeting approved all agenda items on Tuesday. The pharmaceutical company from Leiden reported this after the meeting.
Read more
2024-05-21 (iex.nl)
Pharming annual meeting agrees to all agenda items
Pharming's annual meeting approved all agenda items on Tuesday. The pharmaceutical company from Leiden reported this after the meeting.
Read more
2024-05-20 (ceo.ca)
Pharming Group to participate in May investor conference, by @GlobeNewswire
Leiden, the Netherlands, May 20, 2024: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) announces that Pharming’s management will participate in the following investor conference in the month of May:
Read more
2024-05-20 (ceo.ca)
Pharming Group to participate in May investor conference, by @GlobeNewswire
Leiden, the Netherlands, May 20, 2024: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) announces that Pharming’s management will participate in the following investor conference in the month of May:
Read more
2024-05-20 (ceo.ca)
Pharming Group to participate in May investor conference, by @GlobeNewswire
Leiden, the Netherlands, May 20, 2024: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) announces that Pharming’s management will participate in the following investor conference in the month of May:
Read more
2024-05-20 (ceo.ca)
Pharming Group to participate in May investor conference, by @GlobeNewswire
Leiden, the Netherlands, May 20, 2024: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) announces that Pharming’s management will participate in the following investor conference in the month of May:
Read more
2023-08-14 (yahoo.com)
Pharming Group to convene Extraordinary General Meeting of Shareholders
Pharming Group N.V. ("Pharming" or "the Company") (Euronext: PHARM/Nasdaq: PHAR) announces it will hold an Extraordinary General Meeting of Shareholders (EGM) on Monday, September 25, 2023 at 14:00 CEST.
Read more
2021-06-01 (prnewswire.co.uk)
Pharming Group to present at Jefferies Virtual Healthcare Conference
/PRNewswire/ -- Pharming Group N.V. ("Pharming" or "the Company") (Euronext Amsterdam: PHARM) (Nasdaq: PHAR) announces that its Chief Executive Officer, Sijmen...
Read more